110 related articles for article (PubMed ID: 23582948)
1. Interpreting a study on bladder cancer screening.
Inman BA; Abern MR
Eur Urol; 2013 Jul; 64(1):48-50. PubMed ID: 23582948
[No Abstract] [Full Text] [Related]
2. Reply from authors re: Brant A. Inman, Michael R. Abern. Interpreting a study on bladder cancer screening. Eur Urol 2013;64:48-50: the goal of cancer screening: early evaluation of screening for bladder cancer.
Roobol MJ; Bangma CH; Steyerberg EW
Eur Urol; 2013 Jul; 64(1):50-1. PubMed ID: 23623479
[No Abstract] [Full Text] [Related]
3. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of hematuria home screening for bladder cancer in men.
Cai T; Bartoletti R
Cancer; 2007 May; 109(9):1923-4; author reply 1924. PubMed ID: 17357998
[No Abstract] [Full Text] [Related]
5. Hematuria screening for bladder cancer.
Messing EM; Vaillancourt A
J Occup Med; 1990 Sep; 32(9):838-45. PubMed ID: 2074507
[TBL] [Abstract][Full Text] [Related]
6. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
7. Prostate and bladder cancer screening.
Goldstein MM; Messing EM
J Am Coll Surg; 1998 Jan; 186(1):63-74. PubMed ID: 9449601
[No Abstract] [Full Text] [Related]
8. Diagnostics: A flow of information.
Wald C
Nature; 2017 Nov; 551(7679):S48-S50. PubMed ID: 29117161
[No Abstract] [Full Text] [Related]
9. Bladder cancer screening at the Dupont Chambers Works: a new initiative.
Mason TJ; Vogler WJ
J Occup Med; 1990 Sep; 32(9):874-7. PubMed ID: 2074511
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of home dipstick testing for hematuria.
Madeb R; Messing EM
World J Urol; 2008 Feb; 26(1):19-24. PubMed ID: 18040694
[TBL] [Abstract][Full Text] [Related]
11. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project).
Roobol MJ; Bangma CH; el Bouazzaoui S; Franken-Raab CG; Zwarthoff EC
Urol Oncol; 2010; 28(6):686-90. PubMed ID: 21062653
[TBL] [Abstract][Full Text] [Related]
13. Urothelial bladder cancer: biomarkers for detection and screening.
Konety B; Lotan Y
BJU Int; 2008 Nov; 102(9 Pt B):1234-41. PubMed ID: 19035887
[No Abstract] [Full Text] [Related]
14. Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy.
Hedelin H; Jonsson K; Salomonsson K; Boman H
Scand J Urol Nephrol; 2006; 40(1):26-30. PubMed ID: 16452052
[TBL] [Abstract][Full Text] [Related]
15. New opportunities for screening and early detection of bladder cancer.
Mason TJ; Walsh WP; Lee K; Vogler W
J Cell Biochem Suppl; 1992; 16I():13-22. PubMed ID: 1305676
[TBL] [Abstract][Full Text] [Related]
16. Hematuria: definition and screening test methods.
Higashihara E; Nishiyama T; Horie S; Marumo K; Mitarai T; Koyama T; Matsuyama T; Ito K; Yuno T;
Int J Urol; 2008 Apr; 15(4):281-4. PubMed ID: 18380811
[No Abstract] [Full Text] [Related]
17. [Therapy of bladder carcinoma].
Völter D; Keller AJ
Dtsch Med Wochenschr; 1980 Sep; 105(38):1304-5. PubMed ID: 6161771
[No Abstract] [Full Text] [Related]
18. Editorial comment.
Jones JS
Urology; 2010 Jun; 75(6):1283; author reply 1283-4. PubMed ID: 20513490
[No Abstract] [Full Text] [Related]
19. Long-term outcome of hematuria home screening for bladder cancer in men.
Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
[TBL] [Abstract][Full Text] [Related]
20. Screening and monitoring for bladder cancer: refining the use of NMP22.
Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
